On March 23rd, GPHL signed a strategic cooperation agreement with Industry-University-Research Cooperation Platform and Tsinghua Pearl River Delta Research Institute, the locomotive of Guangdong-Hong Kong-Macao Greater Bay Area's scientific and technological innovation. As the leading innovation enterprises of GPHL, Baiyunshan Pharmaceutical Factory and Tsinghua Pearl River Delta Research Institute will start to build a scientific and technological innovation incubation system and industrial investment platform.
Independent research and development of the first generic drug to break the monopoly of foreign capital
At present, Baiyun Mountain has three main business segments: Danan Medicine, Big Health and Big Commerce. One of the core backbones of Nanyao is the generic drug "Ginger" of sildenafil citrate. This product is the first generic drug independently developed by Baiyunshan Pharmaceutical Factory after 16 years' efforts. It embodies the painstaking efforts of the high-tech research team of Baiyunshan Pharmaceutical Factory, and has high quality completely equivalent to the original research products. The listing of this product also broke the market monopoly of foreign-funded enterprises in the domestic ed drug market for 13 years.
In 2020, Jinge sold 78,345,200 pieces, the sales volume increased by 26.86% compared with the previous year, and the revenue increased by 10.6% to 833 million yuan.
In fact, since the listing of 20 14, Jinge has been well recognized by the market, and its market sales volume and share have increased year by year: 20 17-20 19, and this product ranks first in Tmall's "double1kloc-0/"drug trade for three consecutive years; Minenet data shows that in 20 18 years, its sales volume reached more than twice that of the original research products, accounting for 66.85%, becoming the TOP 1 brand of ed sales. In 20 19, the market share and occupation rate were the first; Last year, all three specifications of Jinge passed the consistency evaluation of national generic drugs, which further boosted Jinge's domestic market share and sales.
"Compared with the same category, this product is of high quality and low price, and it is completely bioequivalent to the original product, but it is listed at a price that the single dosage is reduced by nearly 60%, which really reduces the patient's medication burden." According to the person in charge of Baiyunshan Pharmaceutical Factory of GPHL, the company is also innovating in marketing methods, combining fashion and grounding gas to further expand the market. For example, in recent years, the company has realized the interaction with fans through the official WeChat, created the character image of "Jin Gege", disseminated and popularized the knowledge of men's health, attracted the attention of many young people, and the consumer groups have been expanding. Established Baiyun Mountain Jinger pulmonary hypertension love assistance project with Beijing Aixico, Zhong Nanshan Foundation and other public welfare organizations, and invested millions of yuan to accurately subsidize patients with pulmonary hypertension who are suitable for taking Jinger and expand the pulmonary hypertension drug market.
Baiyunshan pharmaceutical factory is known as "innovative gene"
Over the years, GPHL has constantly pushed enterprises and R&D teams to keep up with the market, and constantly forced scientific research and innovation, as well as basic research in the medical field, to create its own "moat" of competition. Among them, Baiyunshan Pharmaceutical Factory is the "scientific research leader" of Guangzhou Pharmaceutical Group, and has made remarkable achievements in innovative research for many years.
Besides Jinge, Baiyunshan Pharmaceutical General Factory also developed the first cephalosporin with independent intellectual property rights in China-Ceftimidine, and successfully passed the clinical approval of a new drug, Ceftimidine Sodium (1. 1), which filled the gap between the new drug, Ceftimidine Sodium (1. 1) in China in recent 20 years.
Since 2020, the General Factory has successively signed strategic cooperation agreements on new drugs with Wuxi PharmaTech and Chengdu Pioneer, and built multi-dimensional cooperation modes and areas in the fields of small molecule innovative drug research and development, key core technology research, scientific and technological achievements transformation platform, and new drug research and development cooperation.
On March 23rd this year, GPHL signed a strategic cooperation agreement with Industry-University-Research Cooperation Platform and Tsinghua Pearl River Delta Research Institute, the locomotive of Guangdong-Hong Kong-Macao Greater Bay Area's scientific and technological innovation. As a pilot enterprise, Baiyunshan Pharmaceutical General Factory will start to build a scientific and technological innovation incubation system and industrial investment platform with Tsinghua Pearl River Delta Research Institute, so as to absorb high-level talents and social capital more widely, form an enabling platform-based ecology, and incubate and transform a number of new drug projects.
In addition, it is reported that the R&D team of Baiyunshan Pharmaceutical General Factory has completed the urgent scientific research work on raloxivir, and now it has mastered the key technology of treating potential drug injection raloxivir in COVID-19.
Redcevir is a broad-spectrum antiviral drug and a potential drug for treating coronavirus pneumonia-19. It was originally developed for Ebola virus and used for SARS and Middle East Respiratory Syndrome, which belong to the same coronavirus.
This year is the first year that China entered the 14th Five-Year Plan. According to the strategic layout of GPHL, we will further intensify scientific and technological innovation, accelerate the pace of innovation and development, and build a world-class biomedical health enterprise with distinctive industrial characteristics and cultural characteristics. As the "backbone" of the group's scientific research and innovation, Baiyunshan Pharmaceutical General Factory will also play a more important role.